Point-of-care ultrasound and falls in patients after cardiac surgery: A multicentre observational study
Published
September 6, 2025
Paper ID
PAP-000107
Status
Published
DOI
10.65712/tmj.test000365
Advance Services
Abstract
Background: Earlier studies of point-of-care ultrasound were small or single-centre. Methods: Analyses were adjusted for age, sex and baseline severity. Results: Serious adverse events were rare and similar between groups. Effects were consistent across prespecified subgroups. Conclusion: Residual confounding cannot be excluded.
Introduction
Practice around point-of-care ultrasound varies widely between centres. falls remains a leading cause of avoidable harm among patients after cardiac surgery. Earlier studies of point-of-care ultrasound were small or single-centre.
Earlier studies of point-of-care ultrasound were small or single-centre. falls remains a leading cause of avoidable harm among patients after cardiac surgery. Guidelines make only a weak recommendation on point-of-care ultrasound.
Materials and Methods
Analyses were adjusted for age, sex and baseline severity. Missing data were handled with multiple imputation.
We conducted a multicentre observational study across 7 centres between 2020 and 2022. Eligible participants were patients after cardiac surgery. The primary outcome was falls, assessed blind to allocation.
Eligible participants were patients after cardiac surgery. Analyses were adjusted for age, sex and baseline severity. Missing data were handled with multiple imputation.
Results
Effects were consistent across prespecified subgroups. 4100 participants were included (median age 60 years).
4292 participants were included (median age 77 years). 2198 participants were included (median age 68 years).
The adjusted odds ratio was 0.86 (95% CI 0.42 to 0.85). Serious adverse events were rare and similar between groups. The adjusted odds ratio was 0.81 (95% CI 0.30 to 0.67). 3968 participants were included (median age 67 years).
| Group | n | Events |
|---|---|---|
| Male | 858 | 30 |
| Centre B | 665 | 75 |
| Centre B | 892 | 101 |
| Centre A | 97 | 14 |
Values are n (%) unless stated otherwise.

Shown for patients after cardiac surgery; error bars are 95% confidence intervals.
Serious adverse events were rare and similar between groups. falls occurred in 6% of the intervention group versus 37% of controls. 2406 participants were included (median age 67 years). falls occurred in 21% of the intervention group versus 17% of controls.
falls occurred in 5% of the intervention group versus 31% of controls. falls occurred in 12% of the intervention group versus 30% of controls.
Discussion
Implementation will depend on staffing, cost and local protocols. Future work should test point-of-care ultrasound in a pragmatic multicentre trial.
Residual confounding cannot be excluded. Implementation will depend on staffing, cost and local protocols.
Future work should test point-of-care ultrasound in a pragmatic multicentre trial. These findings suggest that point-of-care ultrasound is associated with better falls in patients after cardiac surgery. Implementation will depend on staffing, cost and local protocols.
Residual confounding cannot be excluded. Implementation will depend on staffing, cost and local protocols.
These findings suggest that point-of-care ultrasound is associated with better falls in patients after cardiac surgery. Future work should test point-of-care ultrasound in a pragmatic multicentre trial.
Conclusions
Point-of-care ultrasound is a reasonable option for patients after cardiac surgery to improve falls.
References
1. Zhang X, Larsen X, et al. Delayed cord clamping and 30-day readmission. N Engl J Med. 2009;190(7):204-1484.
2. Nakamura X, Kim A, et al. An enhanced recovery pathway and acute kidney injury. Lancet. 2019;223(6):503-981.
3. Novak Q, Schmidt C, et al. Telemedicine follow-up and time to diagnosis. JAMA. 2009;63(3):106-1068.
4. Volkov X, Mensah R, et al. Delayed cord clamping and length of stay. BMJ. 2012;323(5):721-1215.
5. Yilmaz I, Okafor R, et al. Delayed cord clamping and glycaemic control. N Engl J Med. 2018;116(4):691-1387.
6. Patel G, Rahman G, et al. SGLT2 inhibitors and emergency department revisits. BMJ. 2021;358(4):352-1171.
7. Herrera Q, Herrera X, et al. Pharmacist-led medication review and chronic pain scores. Crit Care Med. 2024;16(6):385-1128.
Appendices
Supplementary tables are available on request.